BEVERLY HALL LORELL, M.D.
Osteopathic Medicine in Washington, DC
License number
DC 42092
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
1700 NW King & Spalding, Washington, DC 20006
100 Winding River Rd, Needham, MA 02492
100 Winding River Rd, Needham, MA 02492
Phone
(202) 383-8937
(781) 237-7241
(781) 237-7241
Personal information
See more information about BEVERLY HALL LORELL at radaris.comName
Address
Phone
100 Winding River Rd, Needham, MA 02492
330 Brookline Ave, Boston, MA 02215
100 Winding River Rd, Needham, MA 02492
Professional information
Methods For Treating Congestive Heart Failure
US Patent:
6635249, Oct 21, 2003
Filed:
Apr 23, 1999
Appl. No.:
09/298121
Inventors:
Mark Marchionni - Arlington MA
Ralph Kelly - Chestnut Hill MA
Beverly Lorell - Needham MA
Douglas B. Sawyer - Brookline MA
Ralph Kelly - Chestnut Hill MA
Beverly Lorell - Needham MA
Douglas B. Sawyer - Brookline MA
Assignee:
CeNes Pharmaceuticals, Inc. - Cambridge
International Classification:
A61K 39395
US Classification:
4241451, 4241851
Abstract:
The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
Methods For Treating Congestive Heart Failure
US Patent:
8076283, Dec 13, 2011
Filed:
Dec 29, 2009
Appl. No.:
12/655361
Inventors:
Mark Marchionni - Arlington MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Assignee:
Acorda Therapeutics, Inc. - Hawthorne NY
Beth Israel Deaconesss Medical Center - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
Beth Israel Deaconesss Medical Center - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 38/18
US Classification:
514 2, 514 8
Abstract:
The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
Methods For Treating Congestive Heart Failure
US Patent:
8394761, Mar 12, 2013
Filed:
Nov 9, 2011
Appl. No.:
13/292193
Inventors:
Mark Marchionni - Arlington MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
Acorda Therapeutics, Inc. - Ardsley NY
The Brigham and Women's Hospital, Inc. - Boston MA
Acorda Therapeutics, Inc. - Ardsley NY
International Classification:
A61K 38/18
US Classification:
514 2, 514 8
Abstract:
The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
Dr. Beverly H Lorell, Needham MA - MD (Doctor of Medicine)
Specialties:
Cardiology, Interventional Cardiology
Address:
100 Winding River Rd, Needham 02492
Certifications:
Cardiovascular Disease, 1979, Internal Medicine, 1978, Interventional Cardiology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University
Graduated: 1975
Stanford University
Graduated: 1975
Methods For Treating Congestive Heart Failure
US Patent:
7662772, Feb 16, 2010
Filed:
Aug 22, 2003
Appl. No.:
10/646268
Inventors:
Mark Marchionni - Arlington MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Ralph Kelly - Chestnut Hill MA, US
Beverly Lorell - Needham MA, US
Douglas B. Sawyer - Brookline MA, US
Assignee:
Acorda Therapeutics, Inc. - Hawthorne NY
Beth Israel Deaconess Medical Center - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
Beth Israel Deaconess Medical Center - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61K 38/18
US Classification:
514 2, 514 8
Abstract:
The invention features methods of treating or preventing congestive heart failure by administering a polypeptide containing an epidermal growth factor-like domain encoded by a neuregulin gene.
Senior Medical &Amp; Policy Advisor At King &Amp; Spalding Llp
Location:
Washington D.C. Metro Area
Industry:
Medical Practice
Beverly Lorell, Washington DC - Lawyer
Address:
1700 Nw - SUITE 200, Washington, DC 20006
Work:
King & Spalding
Specialties:
Health Care Law, FDA / Healthcare Practice, Healthcare Industry, Pharma: FDA/Healthcare
Links:
Website